Douglas N. Fish

10.7k total citations · 3 hit papers
135 papers, 7.3k citations indexed

About

Douglas N. Fish is a scholar working on Epidemiology, Pharmacology and Molecular Medicine. According to data from OpenAlex, Douglas N. Fish has authored 135 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Epidemiology, 42 papers in Pharmacology and 29 papers in Molecular Medicine. Recurrent topics in Douglas N. Fish's work include Antibiotics Pharmacokinetics and Efficacy (42 papers), Antibiotic Resistance in Bacteria (29 papers) and Pneumonia and Respiratory Infections (15 papers). Douglas N. Fish is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (42 papers), Antibiotic Resistance in Bacteria (29 papers) and Pneumonia and Respiratory Infections (15 papers). Douglas N. Fish collaborates with scholars based in United States, Belgium and United Kingdom. Douglas N. Fish's co-authors include Robert MacLaren, Tyree H. Kiser, Keith M. Olsen, E. Patchen Dellinger, Maureen Bolon, Trish M. Perl, James P. Steinberg, Douglas Slain, Robert G. Sawyer and Dale W. Bratzler and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Douglas N. Fish

133 papers receiving 7.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical practice guidelines for antimicrobial prophylaxis in surgery

2013 1.5k citations Douglas N. Fish et al. profile →
Clinical Practice Guidelines for Antimicrobial Prophylaxis in Surgery

2013 806 citations Douglas N. Fish et al. profile →
ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment

2016 613 citations Douglas N. Fish et al. profile →

Peers

Countries citing papers authored by Douglas N. Fish

Since Specialization

Citations

This map shows the geographic impact of Douglas N. Fish's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas N. Fish with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas N. Fish more than expected).

Fields of papers citing papers by Douglas N. Fish

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas N. Fish. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas N. Fish. The network helps show where Douglas N. Fish may publish in the future.

Co-authorship network of co-authors of Douglas N. Fish

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas N. Fish. A scholar is included among the top collaborators of Douglas N. Fish based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas N. Fish. Douglas N. Fish is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluation of Oral Amoxicillin/Clavulanate for Urinary Tract Infections Caused by Ceftriaxone Non-Susceptible Enterobacterales 2024 ·SHILAP Revista de lepidopterología ·(unknown), Meghan N. Jeffres, Kyle C. Molina, Matthew A. Miller, (unknown), Douglas N. Fish	1
2	Real-World Use of Tedizolid Phosphate for 28 Days or More: A Case Series Describing Tolerability and Clinical Success 2022 ·Open Forum Infectious Diseases ·Taylor Morrisette, Kyle C. Molina, (unknown), Scott W. Mueller, (unknown), Martin Kršák, Matthew A. Miller, Douglas N. Fish	12
3	A Just-in-Time Implementation of an Extension for Community Health Outcomes (ECHO) Program for Support of Primary Care During the COVID-19 Pandemic 2021 ·The Journal of the American Board of Family Medicine ·(unknown), (unknown), Joseph J. Saseen, Alexis Burakoff, Douglas N. Fish, (unknown), (unknown), John F. Thomas	2
4	The Emerging Role of β-Lactams in the Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections 2020 ·Antimicrobial Agents and Chemotherapy ·Kyle C. Molina, Taylor Morrisette, Matthew A. Miller, Vanthida Huang, Douglas N. Fish	23
5	Oral Vancomycin Prophylaxis as Secondary Prevention Against Clostridioides difficile Infection in the Hematopoietic Stem Cell Transplantation and Hematologic Malignancy Population 2019 ·Biology of Blood and Marrow Transplantation ·Taylor Morrisette, (unknown), Matthew A. Miller, Scott W. Mueller, Valida Bajrovic, Maheen Z. Abidi, Esther Benamu, (unknown), Gerard R. Barber, (unknown), Jennifer Tobin, Douglas N. Fish, Jonathan A. Gutman	30
6	A comparison of safety and outcomes with cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bloodstream infections 2018 ·Journal of Microbiology Immunology and Infection ·Matthew A. Miller, Douglas N. Fish, Gerard R. Barber, Michelle Barron, (unknown), Pierre Moine, Scott W. Mueller	22
7	935 2012 ·Critical Care Medicine ·(unknown), Charles B. Foster, Tyree H. Kiser, Scott W. Mueller, Deb Sherman, Robert MacLaren, (unknown), Douglas N. Fish	1
8	Evaluation of valganciclovir pharmacokinetics in lung transplant recipients 2012 ·The Journal of Heart and Lung Transplantation ·Tyree H. Kiser, Douglas N. Fish, Martin R. Zamora	15
9	Evaluation of Vancomycin and Daptomycin Potency Trends (MIC Creep) against Methicillin-Resistant Staphylococcus aureus Isolates Collected in Nine U.S. Medical Centers from 2002 to 2006 2009 ·Antimicrobial Agents and Chemotherapy ·Hélio S. Sader, Paul D. Fey, Douglas N. Fish, Ajit P. Limaye, George A. Pankey, James J. Rahal, Michael J. Rybak, David R. Snydman, Lisa L. Steed, Ken B. Waites, Ronald N. Jones	107
10	Evaluation of gatifloxacin pharmacokinetics and pharmacodynamics in severely ill adults in a medical Intensive Care Unit 2007 ·International Journal of Antimicrobial Agents ·Douglas N. Fish	10
11	A Strategy to Develop Advanced Pharmacy Practice Experiences 2007 ·American Journal of Pharmaceutical Education ·Christopher Turner, (unknown), Joel Giles, (unknown), Laura Hansen, Joseph J. Saseen, (unknown), (unknown), Ralph J. Altiere, Jacquelyn Bainbridge, Robert L. Page, Charles D. Sintek, Sheryl F. Vondracek, (unknown), Douglas N. Fish	1
12	Enteral Glutamine Supplementation in Critically Ill Patients with Burn Injuries: A Retrospective Case‐Control Evaluation 2006 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·(unknown), Douglas N. Fish, Rose Jung, Robert MacLaren	15
13	Nosocomial Infections Due to Multidrug‐Resistant Pseudomonas aeruginosa: Epidemiology and Treatment Options 2005 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Marilee D. Obritsch, Douglas N. Fish, Robert MacLaren, Rose Jung	279
14	Telithromycin 2004 ·Drugs ·Douglas N. Fish	0
15	Acyclovir concentrations in human breast milk after valaciclovir administration 2002 ·American Journal of Obstetrics and Gynecology ·Jeanne S. Sheffield, Douglas N. Fish, Lisa M. Hollier, (unknown), B. J. Nobles, George D. Wendel	15
16	Valacyclovir inhibition of recovery of ocular herpes simplex virus type 1 after experimental reactivation by laser in situ keratomileusis 2001 ·Journal of Cataract & Refractive Surgery ·Deepinder K. Dhaliwal, Eric G. Romanowski, Kathleen A. Yates, (unknown), Francis S. Mah, Douglas N. Fish, (unknown)	24
17	The Effect of Hemodialysis on Isoniazid, Rifampin, Pyrazinamide, and Ethambutol 1999 ·American Journal of Respiratory and Critical Care Medicine ·(unknown), Douglas N. Fish, David M. Spiegel, James M. Childs, Charles A. Peloquin	43
18	Levofloxacin, a Second‐Generation Fluoroquinolone 1998 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Donald S. North, Douglas N. Fish, (unknown)	99
19	Development of Resistance During Antimicrobial Therapy: A Review of Antibiotic Classes and Patient Characteristics in 173 Studies 1995 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Douglas N. Fish, Stephen C. Piscitelli, Larry H. Danziger	137
20	Variable Disposition of Ciprofloxacin in Critically Ill Patients Undergoing Continuous Arteriovenous Hemodiafiltration 1995 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Douglas N. Fish, Jacquelyn Bainbridge, Charles A. Peloquin	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact